These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22888246)

  • 1. Enhanced absorption of hydroxysafflor yellow A using a self-double-emulsifying drug delivery system: in vitro and in vivo studies.
    Lv LZ; Tong CQ; Lv Q; Tang XJ; Li LM; Fang QX; Yu J; Han M; Gao JQ
    Int J Nanomedicine; 2012; 7():4099-107. PubMed ID: 22888246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of enhanced oral absorption of hydrophilic drug incorporated in hydrophobic nanoparticles.
    Lv LZ; Tong CQ; Yu J; Han M; Gao JQ
    Int J Nanomedicine; 2013; 8():2709-17. PubMed ID: 23935363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A.
    Zhao B; Gu S; Du Y; Shen M; Liu X; Shen Y
    Int J Pharm; 2018 Jan; 535(1-2):164-171. PubMed ID: 29107614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-double-emulsifying drug delivery system (SDEDDS): a new way for oral delivery of drugs with high solubility and low permeability.
    Qi X; Wang L; Zhu J; Hu Z; Zhang J
    Int J Pharm; 2011 May; 409(1-2):245-51. PubMed ID: 21356300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced effect and mechanism of water-in-oil microemulsion as an oral delivery system of hydroxysafflor yellow A.
    Qi J; Zhuang J; Wu W; Lu Y; Song Y; Zhang Z; Jia J; Ping Q
    Int J Nanomedicine; 2011; 6():985-91. PubMed ID: 21720510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing oral bioavailability of Ca-DTPA by self double emulsifying drug delivery system (SDEDDS).
    Agrawal V; Priyadarshani A; Pathak DP; Sandal N
    Drug Dev Ind Pharm; 2024 Jan; 50(1):78-88. PubMed ID: 38145420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in rats.
    Wang S; Sun M; Ping Q
    Int J Pharm; 2008 Jun; 358(1-2):198-204. PubMed ID: 18417306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel oral preparation of hydroxysafflor yellow A base on a chitosan complex: a strategy to enhance the oral bioavailability.
    Ma GN; Yu FL; Wang S; Li ZP; Xie XY; Mei XG
    AAPS PharmSciTech; 2015 Jun; 16(3):675-82. PubMed ID: 25511808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of Self-Double Emulsifying Drug Delivery System Using Design of Experiments for Enhanced Oral Bioavailability of Gentamicin: In-vitro, Ex-vivo and In-vivo Studies.
    Bhattacharjee A; Chaulya NC; Mukhopadhyay G; Chakraborty A; Mondal B
    J Pharm Sci; 2024 Mar; 113(3):659-668. PubMed ID: 37607594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanisms for enhanced oral absorption of hydroxysafflor yellow A by chuanxiong volatile oil.
    Qi J; Sun M; Ping Q; Zhuang J; Li J; Peddie F; Song Y
    Planta Med; 2010 May; 76(8):786-92. PubMed ID: 20033864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and excretion of hydroxysafflor yellow A, a potent neuroprotective agent from safflower, in rats and dogs.
    Chu D; Liu W; Huang Z; Liu S; Fu X; Liu K
    Planta Med; 2006 Apr; 72(5):418-23. PubMed ID: 16557455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal Delivery of Compounds with Different Lipophilicity and Molecular Weight from W/O Microemulsions Analyzed by UPLC-QTOF/ MS and LC-MS/MS.
    Lin H; Michniak-Kohn B; Xia Z; Xu L; Kang Q; Chen C; Ma S; Wu Q
    Curr Drug Deliv; 2018; 15(7):1009-1019. PubMed ID: 29268684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hydroxysafflor yellow A on the activity and mRNA expression of four CYP isozymes in rats.
    Xu RA; Xu ZS; Ge RS
    J Ethnopharmacol; 2014 Feb; 151(3):1141-1146. PubMed ID: 24373810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxysafflor yellow A exerts antioxidant effects in a rat model of traumatic brain injury.
    Wang Y; Zhang C; Peng W; Xia Z; Gan P; Huang W; Shi Y; Fan R
    Mol Med Rep; 2016 Oct; 14(4):3690-6. PubMed ID: 27599591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new solid non-aqueous self-double-emulsifying drug-delivery system for topical application of quercetin.
    Wang Q; Hu C; Zhang H; Zhang Y; Liu T; Qian A; Xia Q
    J Microencapsul; 2016 Dec; 33(8):785-794. PubMed ID: 27875065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced oral bioavailability of oligomeric proanthocyanidins by a self-double-emulsifying drug delivery system.
    Tian Y; Mao X; Sun R; Zhang M; Xia Q
    Food Sci Nutr; 2020 Jul; 8(7):3814-3825. PubMed ID: 32724643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced oral bioavailability of piperine by self-emulsifying drug delivery systems: in vitro, in vivo and in situ intestinal permeability studies.
    Shao B; Cui C; Ji H; Tang J; Wang Z; Liu H; Qin M; Li X; Wu L
    Drug Deliv; 2015; 22(6):740-7. PubMed ID: 24670090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies.
    Zhu H; Wang Z; Ma C; Tian J; Fu F; Li C; Guo D; Roeder E; Liu K
    Planta Med; 2003 May; 69(5):429-33. PubMed ID: 12802724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on pharmacokinetics of hydroxysafflor yellow A in Carthamus tinctorius and its compound preparation in rat].
    Tang J; Ouyang Z; Feng X; Fang J; Cao X
    Zhongguo Zhong Yao Za Zhi; 2011 Aug; 36(16):2246-9. PubMed ID: 22097340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxysafflor yellow A (HSYA) from flowers of Carthamus tinctorius L. and its vasodilatation effects on pulmonary artery.
    Bai Y; Lu P; Han C; Yu C; Chen M; He F; Yi D; Wu L
    Molecules; 2012 Dec; 17(12):14918-27. PubMed ID: 23519263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.